nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—Bone disorder—Methotrexate—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Acitretin—Nausea—Mechlorethamine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Acitretin—Alopecia—Bleomycin—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Acitretin—Jaundice—Mitoxantrone—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Acitretin—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Acitretin—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Acitretin—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Acitretin—Haemoglobin—Carmustine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Acitretin—Urticaria—Teniposide—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Acitretin—Herpes simplex—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Acitretin—Glossitis—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Acitretin—Haemorrhage—Carmustine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Acitretin—Body temperature increased—Teniposide—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Acitretin—Abdominal pain—Teniposide—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Acitretin—Erythema—Bleomycin—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Acitretin—Paraesthesia—Fludarabine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Acitretin—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Acitretin—Haematuria—Mitoxantrone—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Acitretin—Oedema peripheral—Carmustine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Acitretin—Dyspepsia—Fludarabine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Acitretin—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Acitretin—Decreased appetite—Fludarabine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Acitretin—Visual impairment—Carmustine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Acitretin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Acitretin—Fatigue—Fludarabine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Acitretin—Hypoaesthesia—Vincristine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Acitretin—Constipation—Fludarabine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Acitretin—Pain—Fludarabine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Acitretin—Vasculitis—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Acitretin—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Acitretin—Eye disorder—Carmustine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Acitretin—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Acitretin—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Acitretin—Hypersensitivity—Teniposide—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Acitretin—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Acitretin—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Acitretin—Flushing—Carmustine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Acitretin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Acitretin—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Acitretin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Acitretin—Asthenia—Teniposide—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Acitretin—Melaena—Methotrexate—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Acitretin—Malaise—Bleomycin—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Acitretin—Pruritus—Teniposide—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Acitretin—Alopecia—Carmustine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Acitretin—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Acitretin—Body temperature increased—Fludarabine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Acitretin—Erythema—Carmustine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Acitretin—Cough—Bleomycin—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Acitretin—Angiopathy—Vincristine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Acitretin—Diarrhoea—Teniposide—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Acitretin—Chest pain—Bleomycin—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Acitretin—Myalgia—Bleomycin—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Acitretin—Alopecia—Vincristine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Acitretin—Back pain—Carmustine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Acitretin—Discomfort—Bleomycin—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Acitretin—Chills—Mitoxantrone—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Acitretin—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Acitretin—Alopecia—Mitoxantrone—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Acitretin—Vision blurred—Carmustine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Acitretin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Acitretin—Oedema—Bleomycin—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Acitretin—Erythema—Mitoxantrone—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Acitretin—Infection—Bleomycin—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Acitretin—Back pain—Vincristine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Acitretin—Vomiting—Teniposide—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Acitretin—Asthenia—Fludarabine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Acitretin—Rash—Teniposide—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Acitretin—Dermatitis—Teniposide—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Acitretin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Acitretin—Headache—Teniposide—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Acitretin—Pruritus—Fludarabine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Acitretin—Back pain—Mitoxantrone—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Acitretin—Anorexia—Bleomycin—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Acitretin—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Acitretin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Acitretin—Photosensitivity—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Acitretin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Acitretin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Acitretin—Nausea—Teniposide—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Acitretin—Chest pain—Carmustine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Acitretin—Myalgia—Carmustine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Acitretin—Anxiety—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Acitretin—Paraesthesia—Bleomycin—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Acitretin—Malaise—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Acitretin—Oedema—Carmustine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Acitretin—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Acitretin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Acitretin—Myalgia—Vincristine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Acitretin—Visual disturbance—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Acitretin—Cough—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Acitretin—Infection—Carmustine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Acitretin—Vomiting—Fludarabine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Acitretin—Rash—Fludarabine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Acitretin—Dermatitis—Fludarabine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Acitretin—Pain—Bleomycin—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Acitretin—Headache—Fludarabine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Acitretin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Acitretin—Chest pain—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Acitretin—Myalgia—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Acitretin—Anxiety—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Acitretin—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Acitretin—Discomfort—Mitoxantrone—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Acitretin—Oedema—Vincristine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Acitretin—Anorexia—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Acitretin—Infection—Vincristine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Acitretin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Acitretin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Acitretin—Oedema—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Acitretin—Nausea—Fludarabine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Acitretin—Infection—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Acitretin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Acitretin—Urticaria—Bleomycin—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Acitretin—Anorexia—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Acitretin—Body temperature increased—Bleomycin—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Acitretin—Insomnia—Carmustine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Acitretin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Acitretin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Acitretin—Paraesthesia—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Acitretin—Somnolence—Carmustine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Acitretin—Anorexia—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Acitretin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Acitretin—Decreased appetite—Carmustine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Acitretin—Insomnia—Vincristine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Acitretin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Acitretin—Paraesthesia—Vincristine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Acitretin—Pain—Carmustine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Acitretin—Constipation—Carmustine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Acitretin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Acitretin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Acitretin—Decreased appetite—Vincristine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Acitretin—Somnolence—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Acitretin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Acitretin—Feeling abnormal—Carmustine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Acitretin—Fatigue—Vincristine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Acitretin—Asthenia—Bleomycin—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Acitretin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Acitretin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Acitretin—Pain—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Acitretin—Constipation—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Acitretin—Pruritus—Bleomycin—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Acitretin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Acitretin—Fatigue—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Acitretin—Pancreatitis—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Acitretin—Pain—Mitoxantrone—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Acitretin—Constipation—Mitoxantrone—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Acitretin—Abdominal pain—Carmustine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Acitretin—Body temperature increased—Carmustine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Acitretin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Acitretin—Pancytopenia—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Acitretin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Acitretin—Dysuria—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Acitretin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Acitretin—Abdominal pain—Vincristine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Acitretin—Body temperature increased—Vincristine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Acitretin—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Acitretin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Acitretin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000996	0.000996	CcSEcCtD
Acitretin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000994	0.000994	CcSEcCtD
Acitretin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000991	0.000991	CcSEcCtD
Acitretin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000991	0.000991	CcSEcCtD
Acitretin—Vomiting—Bleomycin—lymphatic system cancer	0.000982	0.000982	CcSEcCtD
Acitretin—Depression—Methotrexate—lymphatic system cancer	0.000977	0.000977	CcSEcCtD
Acitretin—Rash—Bleomycin—lymphatic system cancer	0.000974	0.000974	CcSEcCtD
Acitretin—Dermatitis—Bleomycin—lymphatic system cancer	0.000973	0.000973	CcSEcCtD
Acitretin—Asthenia—Carmustine—lymphatic system cancer	0.000968	0.000968	CcSEcCtD
Acitretin—Stomatitis—Methotrexate—lymphatic system cancer	0.000955	0.000955	CcSEcCtD
Acitretin—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000952	0.000952	CcSEcCtD
Acitretin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000949	0.000949	CcSEcCtD
Acitretin—Haematuria—Methotrexate—lymphatic system cancer	0.000934	0.000934	CcSEcCtD
Acitretin—Epistaxis—Methotrexate—lymphatic system cancer	0.000924	0.000924	CcSEcCtD
Acitretin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000924	0.000924	CcSEcCtD
Acitretin—Asthenia—Vincristine—lymphatic system cancer	0.000924	0.000924	CcSEcCtD
Acitretin—Diarrhoea—Carmustine—lymphatic system cancer	0.000923	0.000923	CcSEcCtD
Acitretin—Nausea—Bleomycin—lymphatic system cancer	0.000918	0.000918	CcSEcCtD
Acitretin—Asthenia—Mitoxantrone—lymphatic system cancer	0.0009	0.0009	CcSEcCtD
Acitretin—Dizziness—Carmustine—lymphatic system cancer	0.000892	0.000892	CcSEcCtD
Acitretin—Haemoglobin—Methotrexate—lymphatic system cancer	0.000884	0.000884	CcSEcCtD
Acitretin—Diarrhoea—Vincristine—lymphatic system cancer	0.000881	0.000881	CcSEcCtD
Acitretin—Hepatitis—Methotrexate—lymphatic system cancer	0.000879	0.000879	CcSEcCtD
Acitretin—Haemorrhage—Methotrexate—lymphatic system cancer	0.000879	0.000879	CcSEcCtD
Acitretin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000873	0.000873	CcSEcCtD
Acitretin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000858	0.000858	CcSEcCtD
Acitretin—Vomiting—Carmustine—lymphatic system cancer	0.000858	0.000858	CcSEcCtD
Acitretin—Dizziness—Vincristine—lymphatic system cancer	0.000851	0.000851	CcSEcCtD
Acitretin—Rash—Carmustine—lymphatic system cancer	0.00085	0.00085	CcSEcCtD
Acitretin—Dermatitis—Carmustine—lymphatic system cancer	0.00085	0.00085	CcSEcCtD
Acitretin—Visual impairment—Methotrexate—lymphatic system cancer	0.000847	0.000847	CcSEcCtD
Acitretin—Headache—Carmustine—lymphatic system cancer	0.000845	0.000845	CcSEcCtD
Acitretin—Eye disorder—Methotrexate—lymphatic system cancer	0.000822	0.000822	CcSEcCtD
Acitretin—Tinnitus—Methotrexate—lymphatic system cancer	0.00082	0.00082	CcSEcCtD
Acitretin—Vomiting—Vincristine—lymphatic system cancer	0.000819	0.000819	CcSEcCtD
Acitretin—Rash—Vincristine—lymphatic system cancer	0.000812	0.000812	CcSEcCtD
Acitretin—Dermatitis—Vincristine—lymphatic system cancer	0.000811	0.000811	CcSEcCtD
Acitretin—Headache—Vincristine—lymphatic system cancer	0.000807	0.000807	CcSEcCtD
Acitretin—Nausea—Carmustine—lymphatic system cancer	0.000801	0.000801	CcSEcCtD
Acitretin—Angiopathy—Methotrexate—lymphatic system cancer	0.000798	0.000798	CcSEcCtD
Acitretin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000797	0.000797	CcSEcCtD
Acitretin—Immune system disorder—Methotrexate—lymphatic system cancer	0.000794	0.000794	CcSEcCtD
Acitretin—Rash—Mitoxantrone—lymphatic system cancer	0.000791	0.000791	CcSEcCtD
Acitretin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00079	0.00079	CcSEcCtD
Acitretin—Chills—Methotrexate—lymphatic system cancer	0.000789	0.000789	CcSEcCtD
Acitretin—Headache—Mitoxantrone—lymphatic system cancer	0.000785	0.000785	CcSEcCtD
Acitretin—Alopecia—Methotrexate—lymphatic system cancer	0.000777	0.000777	CcSEcCtD
Acitretin—Erythema—Methotrexate—lymphatic system cancer	0.000765	0.000765	CcSEcCtD
Acitretin—Nausea—Vincristine—lymphatic system cancer	0.000765	0.000765	CcSEcCtD
Acitretin—Dysgeusia—Methotrexate—lymphatic system cancer	0.00075	0.00075	CcSEcCtD
Acitretin—Nausea—Mitoxantrone—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Acitretin—Back pain—Methotrexate—lymphatic system cancer	0.00074	0.00074	CcSEcCtD
Acitretin—Vision blurred—Methotrexate—lymphatic system cancer	0.000721	0.000721	CcSEcCtD
Acitretin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00071	0.00071	CcSEcCtD
Acitretin—Malaise—Methotrexate—lymphatic system cancer	0.00069	0.00069	CcSEcCtD
Acitretin—Cough—Methotrexate—lymphatic system cancer	0.000668	0.000668	CcSEcCtD
Acitretin—Arthralgia—Methotrexate—lymphatic system cancer	0.000652	0.000652	CcSEcCtD
Acitretin—Chest pain—Methotrexate—lymphatic system cancer	0.000652	0.000652	CcSEcCtD
Acitretin—Myalgia—Methotrexate—lymphatic system cancer	0.000652	0.000652	CcSEcCtD
Acitretin—Discomfort—Methotrexate—lymphatic system cancer	0.000644	0.000644	CcSEcCtD
Acitretin—Infection—Methotrexate—lymphatic system cancer	0.000621	0.000621	CcSEcCtD
Acitretin—Skin disorder—Methotrexate—lymphatic system cancer	0.000607	0.000607	CcSEcCtD
Acitretin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000604	0.000604	CcSEcCtD
Acitretin—Anorexia—Methotrexate—lymphatic system cancer	0.000595	0.000595	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000569	0.000569	CcSEcCtD
Acitretin—Insomnia—Methotrexate—lymphatic system cancer	0.000565	0.000565	CcSEcCtD
Acitretin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000561	0.000561	CcSEcCtD
Acitretin—Somnolence—Methotrexate—lymphatic system cancer	0.000555	0.000555	CcSEcCtD
Acitretin—Dyspepsia—Methotrexate—lymphatic system cancer	0.00055	0.00055	CcSEcCtD
Acitretin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000543	0.000543	CcSEcCtD
Acitretin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000539	0.000539	CcSEcCtD
Acitretin—Fatigue—Methotrexate—lymphatic system cancer	0.000539	0.000539	CcSEcCtD
Acitretin—Pain—Methotrexate—lymphatic system cancer	0.000534	0.000534	CcSEcCtD
Acitretin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000515	0.000515	CcSEcCtD
Acitretin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000511	0.000511	CcSEcCtD
Acitretin—Urticaria—Methotrexate—lymphatic system cancer	0.000496	0.000496	CcSEcCtD
Acitretin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000494	0.000494	CcSEcCtD
Acitretin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000494	0.000494	CcSEcCtD
Acitretin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00046	0.00046	CcSEcCtD
Acitretin—Asthenia—Methotrexate—lymphatic system cancer	0.000448	0.000448	CcSEcCtD
Acitretin—Pruritus—Methotrexate—lymphatic system cancer	0.000442	0.000442	CcSEcCtD
Acitretin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000427	0.000427	CcSEcCtD
Acitretin—Dizziness—Methotrexate—lymphatic system cancer	0.000413	0.000413	CcSEcCtD
Acitretin—Vomiting—Methotrexate—lymphatic system cancer	0.000397	0.000397	CcSEcCtD
Acitretin—Rash—Methotrexate—lymphatic system cancer	0.000394	0.000394	CcSEcCtD
Acitretin—Dermatitis—Methotrexate—lymphatic system cancer	0.000394	0.000394	CcSEcCtD
Acitretin—Headache—Methotrexate—lymphatic system cancer	0.000391	0.000391	CcSEcCtD
Acitretin—Nausea—Methotrexate—lymphatic system cancer	0.000371	0.000371	CcSEcCtD
